Early research (Phase 1)Study completedNCT00439010
What this trial is testing
Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects
Who this might be right for
Alzheimers Disease
Molecular NeuroImaging 30